Who has invested in I-Mab Biopharma?

No investors are named on the public record for I-Mab Biopharma yet.

I-Mab Biopharma Funding: $500M Raised, Post-IPO Equity

I-Mab Biopharma funding overview

I-Mab Biopharma is based in Shanghai, China. I-Mab Biopharma has raised $500M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Post-IPO Equity.

I-Mab Biopharma at a glance

Total raised: $500M
Latest round: Post-IPO Equity
Headquarters: Shanghai, China

Frequently asked about I-Mab Biopharma funding

How much has I-Mab Biopharma raised?: I-Mab Biopharma has raised $500M in total disclosed funding across the rounds on record.
Who has invested in I-Mab Biopharma?: No investors are named on the public record for I-Mab Biopharma yet.
What was the latest I-Mab Biopharma funding round?: The most recent disclosed round is a Post-IPO Equity.
Where is I-Mab Biopharma based?: I-Mab Biopharma is based in Shanghai, China.

Totals shown for I-Mab Biopharma aggregate every disclosed round on file. To see how that compares, browse the companies in Shanghai and the investors behind them below.

I-Mab Biopharma Funding: $500M Raised, Post-IPO Equity

I-Mab Biopharma funding overview

I-Mab Biopharma at a glance

Frequently asked about I-Mab Biopharma funding

Companies related to I-Mab Biopharma (18)

Browse related funding lists (3)